Summary Torrent Pharmaceuticals (TRP) has signed definitive agreements to acquire a 49.2% controlling stake in JB Chemicals and Pharmaceuticals (JBCP) for â‚ą126.4 billion and plans to acquire the remaining 50.8% through a share swap valued at â‚ą140.4 billion. This results in a total enterprise value of â‚ą266.3 billion, marking Torrent’s largest acquisition to date. The…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
